Mark J. Holdbrook - Net Worth and Insider Trading
Mark J. Holdbrook Net Worth
The estimated net worth of Mark J. Holdbrook is at least $142,829 dollars as of 2025-05-12. Mark J. Holdbrook is the V.P., Clinical Affairs of Tarsus Pharmaceuticals Inc and owns about 3,191 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $142,829. Details can be seen in Mark J. Holdbrook's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark J. Holdbrook has not made any transactions after 2023-03-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark J. Holdbrook
Mark J. Holdbrook Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark J. Holdbrook owns 1 companies in total, including Tarsus Pharmaceuticals Inc (TARS) .
Click here to see the complete history of Mark J. Holdbrook’s form 4 insider trades.
Insider Ownership Summary of Mark J. Holdbrook
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2023-03-20 | V.P. & Clinical Affairs |
Mark J. Holdbrook Latest Holdings Summary
Mark J. Holdbrook currently owns a total of 1 stock. Mark J. Holdbrook owns 3,191 shares of Tarsus Pharmaceuticals Inc (TARS) as of March 20, 2023, with a value of $142,829.
Latest Holdings of Mark J. Holdbrook
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2023-03-20 | 3,191 | 44.76 | 142,829 |
Holding Weightings of Mark J. Holdbrook
Mark J. Holdbrook Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark J. Holdbrook has made a total of 2 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the sale of 386 shares on March 20, 2023, which brought Mark J. Holdbrook around $4,995.
Insider Trading History of Mark J. Holdbrook
- 1
Mark J. Holdbrook Trading Performance
Mark J. Holdbrook Ownership Network
Ownership Network List of Mark J. Holdbrook
Ownership Network Relation of Mark J. Holdbrook
Mark J. Holdbrook Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Mark J. Holdbrook is the V.P. & Clinical Affairs of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include director & 10 percent owner & President and CEO Bobak R. Azamian , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Mark J. Holdbrook made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 96,631 shares made by Bobak R. Azamian , a net sale of 22,478 shares made by Bryan Wahl , and a net sale of 19,380 shares made by Dianne C. Whitfield .
In summary, during the past 3 months, insiders sold 68,485 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 68,485 shares. During the past 18 months, 217,703 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 1,000 shares were bought by its insiders, resulting in a net sale of 216,703 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Mark J. Holdbrook Mailing Address
Above is the net worth, insider trading, and ownership report for Mark J. Holdbrook. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark J. Holdbrook's mailing address is: Irvine Ca 92618.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
